Davide Bellini

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Biomaterials Engineering. Top assignees: Fidia Farmaceutici S.p.a., Anika Therapeutics S.r.l., Fidia Advanced Biopolymers S.r.l.. Active years: 1999-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Davide Bellini. Retrieved from https://idiyas.com/inventor/davide-bellini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 170(Granted Patents)

Location History:

Padua, IT (2001 - 2008)
Abano Terme-Padova, IT (2011)
Montegrotto Terme, IT (1999 - 2013)
Albignasego, IT (2013 - 2016)

Company Filing History:

7 out of 88

Fidia Farmaceutici S.p.a.

patents

4 out of 6

Anika Therapeutics S.r.l.

patents

2 out of 30

Fidia Advanced Biopolymers S.r.l.

Years Active: 1999-2016

Loading Chart...

Areas of Expertise:

Biocompatible Biomaterials

Hyaluronic Acid Derivatives

Electrospinning

Surgical Applications

Hydrogel Materials

Spinal Adhesions

Osteoarthrosis

Photocuring

Pharmaceutical Compositions

Carboxy Polysaccharides

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9415091 - Method for preparing biocompatible and biodegradable biomaterials based on collagen and granules of hydroxyapatite/β-tricalcium phosphate for use in surgery, and biomaterials thus obtained (2016-08-16),

2. 8865964 - Biomaterials, their preparation by electrospinning and their use in the biomedical and surgical field (2014-10-21),

3. 8728524 - Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions (2014-05-20),

4. 8575129 - Amides of hyaluronic acid and the derivatives thereof and a process for their preparation (2013-11-05),

5. 8563039 - Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions (2013-10-22),

6. 8349355 - Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields (2013-01-08),

7. 8178663 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2012-05-15),

8. 8178499 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2012-05-15),

9. 7884087 - Amides of hyaluronic acid the derivatives thereof and a process for their preparation (2011-02-08),

10. 7863256 - Amide derivatives of hyaluronic acid in osteoarthrosis (2011-01-04),

11. 7683038 - Percarboxylated polysaccharides, and a process for their preparation (2010-03-23),

12. 7462606 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2008-12-09),

13. 6632802 - Hyaluronic acid esters, threads and biomaterials containing them, and their use in surgery (2003-10-14),

14. 6251876 - Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies (2001-06-26),

15. 5856299 - Highly reactive esters of carboxy polysaccharides and carboxy (1999-01-05),

Title: Innovator Spotlight: Davide Bellini

Introduction

Davide Bellini, hailing from Albignasego, Italy, is a distinguished inventor who has made substantial contributions to the biomedical field. With an impressive portfolio of 15 patents, his work focuses on the development of advanced biomaterials that significantly enhance surgical procedures.

Latest Patents

Among his latest innovations, Bellini has developed a "Method for preparing biocompatible and biodegradable biomaterials based on collagen and granules of hydroxyapatite/β-tricalcium phosphate for use in surgery." This invention is pivotal in maxillofacial surgery, dentistry, aesthetic surgery, and orthopedic surgery. Additionally, he has created a new biomaterial produced through electrospinning techniques, designed for biomedical and surgical applications, broadening the horizons of material science in healthcare.

Career Highlights

Throughout his career, Davide Bellini has been associated with reputable companies such as Fidia Farmaceutici S.p.A. and Anika Therapeutics S.r.l. His dedication to innovation within these organizations underscores his role as a key player in the advancement of medical technologies.

Collaborations

Bellini has had the privilege of collaborating with esteemed colleagues like Lanfranco Callegaro and Vittorio Crescenzi. These partnerships have facilitated the exchange of ideas and further enhanced the quality of research and development within the field.

Conclusion

Davide Bellini's contributions as an inventor continue to shape the landscape of biomedical materials. With a focus on creating effective and biocompatible solutions, he remains at the forefront of innovation, positively impacting surgical practices and patient outcomes. His work exemplifies the importance of research in developing technologies that meet the evolving needs of the medical community.

Profile summary based on public USPTO records.